Designs centered around the patient

20170519news Page 740x540

An article examining SHL’s patient-centric approach to industrial designs was published in the May 2017 issue of OnDrugDelivery Magazine. The article, “Safeguarding User Needs: The Long-Term Legacy of SHL’s Patient-Centric Designs,” features an in-depth talk with SHL Director of Industrial Design, Jochen Ratjen.

In the article, Ratjen speaks about how SHL has capitalized on its near three decades of experience to design drug delivery devices focused on user needs. This includes the establishment of a “user process,” an initiative that will standardize the methods in which usability and human factors are understood throughout the company and incorporated throughout SHL’s design and development process. SHL has also built a comprehensive user study database, and invested in a brand-new design center featuring an interview studio dedicated to understanding patient needs.

Speaking on his personal journey, Ratjen shares some of his most heartfelt experiences interacting with patients during his career at SHL and explains how these memorable interactions have shaped his understanding of patient-centricity.

To read more about Ratjen and SHL’s long-term legacy of patient-centric designs, download the article HERE, or read it online at ONDrugDelivery.

About SHL

SHL Group is a world-leading solution provider in the design, development and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit www.shl.group

 

Share:

Related News